GMB-475 is primarily used in research settings as a selective inhibitor of specific kinase enzymes involved in cellular signaling pathways. It has shown potential in studying cancer cell proliferation due to its ability to modulate key proteins associated with tumor growth. Its application extends to preclinical studies where it helps elucidate the role of targeted kinases in disease mechanisms, particularly in oncology and inflammatory conditions. Due to its specificity, GMB-475 is valuable in developing structure-activity relationship models for drug discovery. It is not intended for therapeutic use in humans and is restricted to laboratory research.